Publikationen 2020

1. Adolf C, Braun LT, Fuss CT, Hahner S, Kunzel H, Handgriff L, Sturm L, Heinrich DA, Schneider H, Bidlingmaier M, Reincke M. Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism. Endocrine. 2020;69:625-633.

2. Amereller F, Kuppers AM, Schilbach K, Schopohl J, Stormann S. Clinical Characteristics of Primary Hypophysitis - A Single-Centre Series of 60 Cases. Exp Clin Endocrinol Diabetes. 2020.

3. Asbach E, Bekeran M, Konig A, Lang K, Hanslik G, Treitl M, Ladurner R, Bidlingmaier M, Beuschlein F, Quinkler M, Reincke M. Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronism - Findings From the German Conn's Registry. Exp Clin Endocrinol Diabetes. 2020;128:246-254.

4. Auer MK, Krumbholz A, Bidlingmaier M, Thieme D, Reisch N. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Neuroendocrinology. 2020;110:938-949.

5. Auer MK, Paizoni L, Hofbauer LC, Rauner M, Chen Y, Schmidt H, Huebner A, Bidlingmaier M, Reisch N. Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency. J Steroid Biochem Mol Biol. 2020;204:105734.

6. Braun LT, Fazel J, Zopp S, Benedix S, Osswald-Kopp A, Riester A, Rubinstein G, Seidensticker M, Beuschlein F, Drey M, Bidlingmaier M, Schmidmaier R, Reincke M. The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2-Year Follow-Up Study. J Bone Miner Res. 2020;35:1711-1717.

7. Constantinescu G, Bidlingmaier M, Gruber M, Peitzsch M, Poitz DM, van Herwaarden AE, Langton K, Kunath C, Reincke M, Deinum J, Lenders JWM, Hofmockel T, Bornstein SR, Eisenhofer G. Mass spectrometry reveals misdiagnosis of primary aldosteronism with scheduling for adrenalectomy due to immunoassay interference. Clin Chim Acta. 2020;507:98-103.

8. Ferrari U, Schmidmaier R, Jung T, Reincke M, Martini S, Schoser B, Bidlingmaier M, Drey M. IGF-I/IGFBP3/ALS deficiency in sarcopenia: low GHBP suggests GH resistance in a subgroup of geriatric patients. J Clin Endocrinol Metab. 2020.

9. Fries CM, Bae YJ, Rayes N, Sandner B, Isermann B, Stumvoll M, Fagotto V, Reincke M, Bidlingmaier M, Mandy V, Kratzsch J, Fenske WK. Prospective evaluation of aldosterone LC-MS/MS-specific cutoffs for the saline infusion test. Eur J Endocrinol. 2020;183:191-201.

10. Gar C, Rottenkolber M, Haenelt M, Potzel AL, Kern-Matschilles S, Then C, Seissler J, Bidlingmaier M, Lechner A. Altered metabolic and hormonal responses to moderate exercise in overweight/obesity. Metabolism. 2020;107:154219.

11. Handgriff L, Adolf C, Heinrich DA, Braun L, Nirschl N, Sturm L, Ladurner R, Ricke J, Seidensticker M, Bidlingmaier M, Reincke M. The Impact of Glucocorticoid Co-Secretion in Primary Aldosteronism on Thyroid Autoantibody Titers During the Course of Disease. Horm Metab Res. 2020;52:404-411.

12. Hinrichs A, Riedel EO, Klymiuk N, Blutke A, Kemter E, Langin M, Dahlhoff M, Kessler B, Kurome M, Zakhartchenko V, Jemiller EM, Ayares D, Bidlingmaier M, Flenkenthaler F, Hrabe de Angelis M, Arnold GJ, Reichart B, Frohlich T, Wolf E. Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies. Xenotransplantation. 2020:e12664.

13. Hofmann I, Kemter E, Theobalt N, Fiedler S, Bidlingmaier M, Hinrichs A, Aichler M, Burkhardt K, Klymiuk N, Wolf E, Wanke R, Blutke A. Linkage between growth retardation and pituitary cell morphology in a dystrophin-deficient pig model of Duchenne muscular dystrophy. Growth Horm IGF Res. 2020;51:6-16.

14. Johar H, Atasoy S, Bidlingmaier M, Henningsen P, Ladwig KH. Married but lonely. Impact of poor marital quality on diurnal cortisol patterns in older people: findings from the cross-sectional KORA-Age study. Stress. 2021;24:36-43.

15. Kaluzny M, Polowczyk B, Bladowska J, Kubicka E, Bidlingmaier M, Bolanowski M. Acromegaly due to ectopic growth hormone-releasing hormone secretion by lung carcinoid. Pol Arch Intern Med. 2020;130:685-687.

16. Kreitschmann-Andermahr I, Siegel S, Unger N, Streetz-van der Werf C, Karges W, Schilbach K, Schroder B, Szybowicz J, Sauerwald J, Zopf K, Grzywotz A, Bidlingmaier M, Sommer H, Strasburger CJ. Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients' perspective. Pituitary. 2020;23:479-487.

17. Ladwig KH, Schriever SC, Atasoy S, Bidlingmaier M, Kruse J, Johar H. Association of generalized and central obesity with serum and salivary cortisol secretion patterns in the elderly: findings from the cross sectional KORA-Age study. Sci Rep. 2020;10:14321.

18. Mende KC, Kellner T, Petersenn S, Honegger J, Evangelista-Zamora R, Droste M, Stalla G, Deutschbein T, Wang Y, Moskopp D, Knappe U, Schilbach K, Flitsch J. Clinical Situation, Therapy, and Follow-Up of Adult Craniopharyngioma. J Clin Endocrinol Metab. 2020;105.

19. Paizoni L, Auer MK, Schmidt H, Hubner A, Bidlingmaier M, Reisch N. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Steroid Biochem Mol Biol. 2020;197:105540.

20. Pfaffle R, Bidlingmaier M, Kreitschmann-Andermahr I, Land C, Partsch CJ, Schwab KO, Sommer H, Backeljauw P, Kanumakala S, Loche S, Zouater H, Strasburger CJ. Safety and Effectiveness of Omnitrope(R), a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study. Horm Res Paediatr. 2020;93:154-163.

21. Riedel EO, Hinrichs A, Kemter E, Dahlhoff M, Backman M, Rathkolb B, Prehn C, Adamski J, Renner S, Blutke A, de Angelis MH, Bidlingmaier M, Schopohl J, Arnold GJ, Frohlich T, Wolf E. Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model. Mol Metab. 2020;36:100978.

22. Then C, Thorand B, Then HL, Meisinger C, Heier M, Peters A, Koenig W, Rathmann W, Bidlingmaier M, Lechner A, Reincke M, Scherberich JE, Seissler J. Serum uromodulin is inversely associated with arterial hypertension and the vasoconstrictive prohormone CT-proET-1 in the population-based KORA F4 study. PLoS One. 2020;15:e0237364.

23. Vogel F, Braun LT, Rubinstein G, Zopp S, Kunzel H, Strasding F, Albani A, Riester A, Schmidmaier R, Bidlingmaier M, Quinkler M, Deutschbein T, Beuschlein F, Reincke M. Persisting Muscle Dysfunction in Cushing's Syndrome Despite Biochemical Remission. J Clin Endocrinol Metab. 2020;105.

24. Wit JM, Bidlingmaier M, de Bruin C, Oostdijk W. A Proposal for the Interpretation of Serum IGF-I Concentration as Part of Laboratory Screening in Children with Growth Failure. J Clin Res Pediatr Endocrinol. 2020;12:130-139.